Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchison China MediTech Ltd (HCM US)
Watchlist
40
Analysis
Health Care
•
Hong Kong
Hutchison China MediTech Ltd develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
08 Sep 2022 08:14
PCAOB and CSRC‘s Agreement on Audit Terms Could Fail - The Real Test of China ADRs Lies Ahead
China ADRs are only a part of Sino-US game, which shouldn't be looked at alone. It’s hard to reach final agreement. The trend of relisting on HKEX...
Xinyao (Criss) Wang
Follow
205 Views
Share
bullish
•
Legend Biotech Corp
•
26 Jul 2022 11:44
Legend Biotech Follow-On - A Little Opportunistic. Last Deal Did Well, After a Large Correction
Legend Biotech Corp (LEGN US), a non-wholly owned subsidiary of Hong Kong-listed Genscript Biotech (1548 HK), is planning to raise up to US$250m in...
Sumeet Singh
Follow
305 Views
Share
bearish
•
Hutchison China MediTech Ltd
•
29 Mar 2022 08:53
Hutchmed China Ltd (13.HK/HCM.US) - Big but Not Strong
Li Ka-shing's original intention for Hutchmed is not on innovative drugs. Hutchmed's current pipeline also does not have core competitiveness. So,...
Xinyao (Criss) Wang
Follow
287 Views
Share
bearish
•
Thematic (Sector/Industry)
•
16 Mar 2022 08:58
The Impact of HFCAA on China ADR (China Healthcare Companies)
We analyzed the points in HFCAA that are difficult for China to accept.Such irreconcilable contradiction could lead to a trend of delisting from...
Xinyao (Criss) Wang
Follow
238 Views
Share
bearish
•
KraneShares CSI China Internet ETF
•
14 Mar 2022 08:59
China ADRs & HFCAA: Pace of Homecoming Listings Should Pick Up & Implications
The SEC naming 5 companies under the HFCAA put China ADRs under pressure last week. The news that the CAC had nixed DIDI's HK listing plans added...
Brian Freitas
Follow
640 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x